Seres Therapeutics, Inc. (MCRB)

Seres Therapeutics Revenue

Seres Therapeutics had revenue of $358.00K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $1.15M. In the year 2025, Seres Therapeutics had annual revenue of $789.00K.

• Revenue (ttm): $1.15M
• Revenue Growth: n/a
• P/S Ratio: 66.87
• Revenue / Employee: $17,379
• Employees: 66
• Market Cap: 76.70M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	789.00K	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	144.93M	111.71M	336.33%
Dec 31, 2020	33.22M	-1.29M	-3.74%
Dec 31, 2019	34.51M	6.24M	22.07%
Dec 31, 2018	28.27M	-3.83M	-11.94%
Dec 31, 2017	32.10M	10.33M	47.48%
Dec 31, 2016	21.77M	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-

Data Source: Fiscal.ai Last updated: May 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error